Addressing ART Safety and Tolerability in Transgender Individuals


Manage episode 349163530 series 2884624
由Player FM以及我们的用户群所搜索的Clinical Care Options, LLC and Clinical Care Options — 版权由出版商所拥有,而不是Player FM,音频直接从出版商的伺服器串流. 点击订阅按钮以查看Player FM更新,或粘贴收取点链接到其他播客应用程序里。

In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:

  • Strategies on how to approach different ARV-related toxicities
  • Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors)
  • Clinically relevant drug–drug interactions related to HIV and gender-affirming care
  • Methods to reduce barriers to ART adherence


Jill Blumenthal, MD, MAS
Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jennifer Cocohoba, PharmD
Department of Clinical Pharmacy
University of California, San Francisco
Women’s HIV Program
University of California San Francisco Medical Center
San Francisco, California

Link to full program:

Follow along with the slides at: